FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Cho Tang

Research Profile

Chemicals & Drugs

Living Beings

Anatomy

Co-author Network

Publications

TOP 3
Ismail Hassan Ismail; Susanne Mårtensson; Deborah Moshinsky; Audie Rice; Cho Tang; Anthony R Howlett; Gerald McMahon; Ola Hammarsten
SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization.
Huiping Guan; A Douglas Laird; Robert Blake; Cho Tang; Chris Liang
Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase.
Neela Patel; Li Sun; Deborah Moshinsky; Hui Chen; Kathleen M Leahy; Phuong Le; Katherine G Moss; Xueyan Wang; Audie Rice; Danny Tam; A Douglas Laird; Xiaoming Yu; Qingling Zhang; Cho Tang; Gerald McMahon; Anthony R Howlett
A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Cho Tang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Ismail Hassan Ismail; Susanne Mårtensson; Deborah Moshinsky; Audie Rice; Cho Tang; Anthony R Howlett; Gerald McMahon; Ola Hammarsten
SU11752 inhibits the DNA-dependent protein kinase and DNA double-strand break repair resulting in ionizing radiation sensitization.
Oncogene 2004;23(4):873-82.
2004: Huiping Guan; A Douglas Laird; Robert Blake; Cho Tang; Chris Liang
Design and synthesis of aminopropyl tetrahydroindole-based indolin-2-ones as selective and potent inhibitors of Src and Yes tyrosine kinase.
Bioorganic & medicinal chemistry letters 2004;14(1):187-90.
2003: Neela Patel; Li Sun; Deborah Moshinsky; Hui Chen; Kathleen M Leahy; Phuong Le; Katherine G Moss; Xueyan Wang; Audie Rice; Danny Tam; A Douglas Laird; Xiaoming Yu; Qingling Zhang; Cho Tang; Gerald McMahon; Anthony R Howlett
A selective and oral small molecule inhibitor of vascular epithelial growth factor receptor (VEGFR)-2 and VEGFR-1 inhibits neovascularization and vascular permeability.
The Journal of pharmacology and experimental therapeutics 2003;306(3):838-45.
2003: Dirk B Mendel; A Douglas Laird; Xiaohua Xin; Sharianne G Louie; James G Christensen; Guangmin Li; Randall E Schreck; Tinya J Abrams; Theresa J Ngai; Leslie B Lee; Lesley J Murray; Jeremy Carver; Emily Chan; Katherine G Moss; Joshua O Haznedar; Juthamas Sukbuntherng; Robert Blake; Li Sun; Cho Tang; Todd Miller; Sheri Shirazian; Gerald McMahon; Julie M Cherrington
In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(1):327-37.
2002: Li Sun; Jean Cui; Congxin Liang; Yong Zhou; Asaad Nematalla; Xueyan Wang; Hui Chen; Cho Tang; James Wei
Rational design of 4,5-disubstituted-5,7-dihydro-pyrrolo[2,3-d]pyrimidin-6-ones as a novel class of inhibitors of epidermal growth factor receptor (EGF-R) and Her2(p185(erbB)) tyrosine kinases.
Bioorganic & medicinal chemistry letters 2002;12(16):2153-7.
2000: A Douglas Laird; Peter Vajkoczy; Laura K Shawver; Andreas Thurnher; Congxin Liang; M Mohammadi; J Schlessinger; Axel Ullrich; Stevan Hubbard; Robert Blake; TA Fong; LM Strawn; Li Sun; Cho Tang; R Hawtin; F Tang; Narmada Shenoy; KP Hirth; Gerald McMahon
SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.
Cancer research 2000;60(15):4152-60.
2000: Li Sun; N Tran; Congxin Liang; S Hubbard; F Tang; Kenneth E Lipson; Randall E Schreck; Y Zhou; Gerald McMahon; Cho Tang
Identification of substituted 3-[(4,5,6, 7-tetrahydro-1H-indol-2-yl)methylene]-1,3-dihydroindol-2-ones as growth factor receptor inhibitors for VEGF-R2 (Flk-1/KDR), FGF-R1, and PDGF-Rbeta tyrosine kinases.
Journal of medicinal chemistry 2000;43(14):2655-63.
1999: Li Sun; N Tran; Congxin Liang; F Tang; A Rice; Randall E Schreck; K Waltz; Laura K Shawver; Gerald McMahon; Cho Tang
Design, synthesis, and evaluations of substituted 3-[(3- or 4-carboxyethylpyrrol-2-yl)methylidenyl]indolin-2-ones as inhibitors of VEGF, FGF, and PDGF receptor tyrosine kinases.
Journal of medicinal chemistry 1999;42(25):5120-30.
1999: T J Powell; Hannah Ben-Bassat; Benjamin Y Klein; Hui Chen; N Shenoy; J McCollough; B Narog; Aviv Gazit; Z Harzstark; Malka Chaouat; Rubina Levitzki; Cho Tang; J McMahon; Laura K Shawver; Alexander Levitzki
Growth inhibition of psoriatic keratinocytes by quinazoline tyrosine kinase inhibitors.
The British journal of dermatology 1999;141(5):802-10.
1999: TA Fong; Laura K Shawver; Li Sun; Cho Tang; H App; T J Powell; Y H Kim; Randall E Schreck; Xueyan Wang; W Risau; Axel Ullrich; KP Hirth; Gerald McMahon
SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.
Cancer research 1999;59(1):99-106.
1998: Li Sun; N Tran; F Tang; H App; P Hirth; Gerald McMahon; Cho Tang
Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases.
Journal of medicinal chemistry 1998;41(14):2588-603.
1997: Laura K Shawver; D P Schwartz; E Mann; Hui Chen; J Tsai; L Chu; L Taylorson; M Longhi; S Meredith; L Germain; J S Jacobs; Cho Tang; Axel Ullrich; Michael Berens; Evan M Hersh; Gerald McMahon; KP Hirth; T J Powell
Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(7):1167-77.
1997: Moosa Mohammadi; Gerald McMahon; Li Sun; Cho Tang; P Hirth; Brian K Yeh; Stevan Hubbard; Joseph Schlessinger
Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors.
Science (New York, N.Y.) 1997;276(5314):955-60.
1996: L M Strawn; Gerald McMahon; H App; Randall E Schreck; W R Kuchler; M P Longhi; T H Hui; Cho Tang; Alexander Levitzki; Aviv Gazit; I Chen; G Keri; László Őrfi; Werner Risau; Ingo Flamme; A Ullrich; KP Hirth; Laura K Shawver
Flk-1 as a target for tumor growth inhibition.
Cancer research 1996;56(15):3540-5.